Ancylostoma caninum Anticoagulant Peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro

Thrombosis and Haemostasis

Volumn 79, Issue 5, 1998, Pages 1041-1047

  Donnelly, Kathleen M ^a   Bromberg, Michael E ^a   Milstone, Aaron ^a   McNiff, Jennifer Madison ^a   Terwilliger, Gordon ^a   Konigsberg, William H ^a   Cappello, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTICOAGULANT AGENT; BINDING PROTEIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; PROTEINASE; THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANCYLOSTOMA CANINUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVE SITE; HOOKWORM; HUMAN; HUMAN CELL; LUNG METASTASIS; MELANOMA CELL; METASTASIS; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SCID MOUSE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031955741     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615117     Document Type: Article

References (44)

1. Murray JC. Coagulation and cancer. Br J Cancer 1991; 64: 422-4.
2. Bick RL, Pegram M. Syndromes of hypercoagulability and thrombosis: a review. Semin Thromb Hemost 1994; 20: 109-32.
3. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62: 14-31.
4. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli, VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992; 18: 104-16.
5. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue. Biochemistry 1985; 24: 5558-67.
6. Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129-35.
7. Boukerche H, Berthier-Vergnes O, Penin F, Tabone E, Lizard G, Bailly M, McGregor JL. Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets. Br J Haematol 1994; 87: 763-72.
8. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89: 11832-6.
9. Klepfish A, Greco A, Karpatkin S. Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 1993; 53: 978-82.
10. Zacharski LR, Memoli VA, Ornstein DL, Rouseau SM, Kisiel W, Kudryk BJ. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 1993; 85: 1225-30.
11. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992; 267: 14151-6.
12. Kirchheimer JC, Christ G, Binder BR. Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme. Eur J Biochem 1989; 181: 103-7.
13. 3 expression on the cell surface. Thromb Res 1992; 68: 233-45.
14. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992; 10: 145-55.
15. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205-9.
16. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229-36.
17. Fischer EG, Ruf W, Mueller BM. Tissue factor-initiated thrombin generation activates the signalling thrombin receptor on malignant melanoma cells. Cancer Res 1995; 55: 1629-32.
18. Stahl A Mueller BM. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 1994; 54: 3066-71.
19. Altieri DC, Stamnes SJ. Protease-dependent T cell activation: Ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation. Cell Immunol 1994; 155: 372-83.
20. Duchosal MA, Rothermel AL, McConahey PJ, Dixon FJ, Altieri DC. In vivo immunosupression by targeting a novel protease receptor. Nature 1996; 380: 352-6.
21. Altieri DC. Xa receptor EPR-1. FASEB J 1995; 9: 860-5.
22. Adida C, Ambrosini G, Plescia J, Crotty PL, Costa J, Altieri DA. Protease receptors in Hodgkin's disease: Expression of the factor Xa receptor, Effector cell protease receptor-1, in Reed-Sternberg cells. Blood 1996; 88: 1457-64.
23. Kakkar AK, Lemoine NR, Stone SR, Altieri DA, Williamson RC. Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells. Clin Molec Pathol 1995; 48: M288-M90.
24. Ambrosini G, Altieri DC. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa: Assignment of critical residues involved in antibody reactivity and ligand binding. J Biol Chem 1996; 271: 1243-8.
25. 88 in factor Xa mediates ligand binding to effector cell protease receptor-1. J Biol Chem 1997; 272: 8340-5.
26. Sakai T, Kisiel W. Binding of human factors X and Xa to Hep G2 and J82 human tumor cell lines: Evidence that factor Xa binds to tumor cells independent of factor Va. J Biol Chem 1990; 265: 9105-13.
27. Kazama Y, Komiyama Y, Kisiel W. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood 1993; 81: 676-82.
28. Nicholoson AC, Nachman RL, Altieri DA, Summers BD, Ruf W, Edgington TS, Hajjar DP. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem 1996; 271: 28407-13.
29. Gajdusek C, Carbon S, Ross R, Nawroth P, Stern D. Activation of coagulation releases endothelial cell mitogens. J Cell Biol 1986; 103: 419-28.
30. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S are potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 2317-20.
31. Cappello M, Vlasuk GP, Bergum PW, Huang S, Hotez PJ. Ancylostoma caninum anticoagulant peptide: A hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA 1995; 92: 6152-6.
32. Stanssens P, Bergum PW, Gansemans Y, Jespers L, Laroche Y, Huang S, Maki S, Messens J, Lauwereys M, Cappello M, Hotez PJ, Lasters I, Vlasuk GP. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA 1996; 93: 2149-54.
33. Cappello M, Hawdon JM, Jones BF, Kennedy WP, Hotez PJ. Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli. Molecular Biochem Parasitol 1996; 80: 113-7.
34. Tuszynski GP, Gasic TB, Gasic GJ. Isolation and characterization of antistasin: An inhibitor of metastasis and coagulation. J Biol Chem 1987; 262: 9718-23.
35. Fodstad O, Aamdal S, McMenamin M, Nesland JM, Pihl A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer 1988; 41: 442-9.
36. Altieri DC, Edgington TS. Identification of effector cell protease receptor-1: a leukocyte-distributed receptor for the serine protease factor Xa. J Immunol 1990; 145: 246-53.
37. Carson SD, Ross SE, Bach R, Guha A. An inhibitory monoclonal antibody against human tissue factor. Blood 1987; 70: 490-3.
38. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-13.
39. Gasic GJ, Viner ED, Budzynski AZ, Gasic GP. Inhibition of lung tumor colonization by leech salivary gland extracts from Haementeria ghilianii. Cancer Res 1983; 43: 1633-6.
40. Rieu P, Ueda T, Haruta I, Sharma CP, Arnout MA. The A-domain of β2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol 1994; 127: 2081-91.
41. Hasan AAK, Cines DB, Ngaiza JR, Jaffe EA, Schmaier AH. High-molcular weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium. Blood 1995; 85: 3134-43.
42. Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272: 9244-51.
43. Esumi N, Fan D, Fidler IJ. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 1991; 51: 4549-56.
44. 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 1996; 271: 29034-42.